Miaolong Lu

834 total citations
18 papers, 607 citations indexed

About

Miaolong Lu is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Miaolong Lu has authored 18 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Miaolong Lu's work include Ubiquitin and proteasome pathways (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Pituitary Gland Disorders and Treatments (5 papers). Miaolong Lu is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Pituitary Gland Disorders and Treatments (5 papers). Miaolong Lu collaborates with scholars based in China, United States and Germany. Miaolong Lu's co-authors include Xianquan Zhan, Ying Long, Wang Ya, Tingting Cheng, Ying Fu, Huichao Huang, Yongheng Chen, Yilu Feng, Ming Guo and Ye Zhang and has published in prestigious journals such as Life Sciences, Cell Death and Disease and Electrophoresis.

In The Last Decade

Miaolong Lu

18 papers receiving 596 citations

Peers

Countries citing papers authored by Miaolong Lu

Since Specialization

Citations

This map shows the geographic impact of Miaolong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miaolong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miaolong Lu more than expected).

Fields of papers citing papers by Miaolong Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miaolong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miaolong Lu. The network helps show where Miaolong Lu may publish in the future.

Co-authorship network of co-authors of Miaolong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Miaolong Lu. A scholar is included among the top collaborators of Miaolong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miaolong Lu. Miaolong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Suberoylanilide Hydroxamic Acid (SAHA) Treatment Reveals Crosstalk Among Proteome, Phosphoproteome, and Acetylome in Nasopharyngeal Carcinoma Cells 2022 ·Frontiers in Genetics ·Huichao Huang, Ying Fu, (unknown), Ye Zhang, Miaolong Lu, Zhuchu Chen, Maoyu Li, Yongheng Chen	4
2	Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics 2022 ·Frontiers in Endocrinology ·Xianquan Zhan, (unknown), Miaolong Lu, (unknown), Jingru Yang, (unknown), (unknown), Shu Zheng, Yuna Guo, Biao Li, Siqi Wen, Jiajia Li, Na Li	4
3	PXDNL activates the motility of urothelial bladder carcinoma cells through the Wnt/β-catenin pathway and has a prognostic value 2022 ·Life Sciences ·Miaolong Lu, Bolong Liu, Dongyang Li, (unknown), Wenbiao Li, Xiangfu Zhou, Hailun Zhan	4
4	N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer 2021 ·The EPMA Journal ·Miaolong Lu, Hailun Zhan, Bolong Liu, Dongyang Li, Wenbiao Li, (unknown), Xiangfu Zhou	24
5	Dissection of Anti-tumor Activity of Histone Deacetylase Inhibitor SAHA in Nasopharyngeal Carcinoma Cells via Quantitative Phosphoproteomics 2020 ·Frontiers in Cell and Developmental Biology ·Huichao Huang, Ying Fu, Ye Zhang, Fang Peng, Miaolong Lu, Yilu Feng, Lin Chen, Zhuchu Chen, Maoyu Li, Yongheng Chen	11
6	Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas 2020 ·The EPMA Journal ·Dan Liu, Jiajia Li, Na Li, Miaolong Lu, Siqi Wen, Xianquan Zhan	18
7	A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma 2020 ·Cell Death and Disease ·Yilu Feng, Ye Zhang, Yi Cai, Ruijie Liu, Miaolong Lu, Tangzhiming Li, Ying Fu, Ming Guo, Huichao Huang, (unknown), Yongheng Chen	79
8	Label-free quantitative identification of abnormally ubiquitinated proteins as useful biomarkers for human lung squamous cell carcinomas 2020 ·The EPMA Journal ·Miaolong Lu, Wei Chen, Wei Zhuang, Xianquan Zhan	18
9	Quantitative Analysis of Proteome in Non-functional Pituitary Adenomas: Clinical Relevance and Potential Benefits for the Patients 2019 ·Frontiers in Endocrinology ·Tingting Cheng, Ya Wang, Miaolong Lu, Xianquan Zhan, (unknown), Biao Li	15
10	The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas 2019 ·Frontiers in Endocrinology ·Miaolong Lu, Wang Ya, Xianquan Zhan	74
11	Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas 2019 ·Frontiers in Endocrinology ·Ying Long, Miaolong Lu, Tingting Cheng, Xianquan Zhan, (unknown), (unknown)	26
12	Quantitative Analysis of Ubiquitinated Proteins in Human Pituitary and Pituitary Adenoma Tissues 2019 ·Frontiers in Endocrinology ·(unknown), Xianquan Zhan, Miaolong Lu, (unknown), Ying Long, Xuejun Li, Dominic M. Desiderio	26
13	TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas 2019 ·The EPMA Journal ·Ya Wang, Tingting Cheng, Miaolong Lu, Yun Mu, (unknown), Xuejun Li, Xianquan Zhan	20
14	The crucial role of multiomic approach in cancer research and clinically relevant outcomes 2018 ·The EPMA Journal ·Miaolong Lu, Xianquan Zhan	164
15	Exploration of variations in proteome and metabolome for predictive diagnostics and personalized treatment algorithms: Innovative approach and examples for potential clinical application 2017 ·Journal of Proteomics ·Xianquan Zhan, Ying Long, Miaolong Lu	54
16	How many proteins can be identified in a 2DE gel spot within an analysis of a complex human cancer tissue proteome? 2017 ·Electrophoresis ·Xianquan Zhan, Haiyan Yang, Fang Peng, Jianglin Li, Yun Mu, Ying Long, Tingting Cheng, (unknown), Li Zhao, Miaolong Lu, Na Li, Maoyu Li, Jianping Liu, Peter R. Jungblut	54
17	Laparoendoscopic Single-Site Retroperitoneoscopic Adrenalectomy Versus Conventional Retroperitoneoscopic Adrenalectomy in Obese Patients 2015 ·Journal of Endourology ·Yang Wang, (unknown), (unknown), Chaohui Wang, Zhi Chen, Miaolong Lu, Zhiqiang Wen, Xiang Chen	11
18	A study on the crosslinking characteristics of Allyl itaconates 1988 ·Reactive Polymers Ion Exchangers Sorbents ·(unknown), (unknown), Miaolong Lu, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact